Your session is about to expire
Singulair vs Flovent
Introduction
For patients suffering from asthma or other types of respiratory conditions, certain medications that control inflammation and ease the symptoms can be life-changing. Singulair and Flovent are two such drugs often prescribed for these conditions. They each have different mechanisms of action but both aim to manage and reduce asthma-related symptoms in patients. Singulair, also known as Montelukast, is a leukotriene receptor antagonist which works by blocking substances in your body called leukotrienes that cause narrowing and swelling of airways in the lungs. On the flip side, Flovent is classified as an inhaled corticosteroid (ICS) drug which primarily acts by reducing inflammation within the bronchial tubes.
Singulair vs Flovent Side By Side
| Attribute | Singulair | Flovent |
|---|---|---|
| Brand Name | Singulair | Flovent |
| Contraindications | Should not be used as a rescue inhaler during an acute asthma attack. Inform healthcare provider about all medications being taken due to potential drug interactions. | Should not be used during an active asthma attack as it will not provide immediate relief. Inform healthcare provider about all medications being taken due to potential drug interactions. |
| Cost | Around $170 for 30 tablets of 10 mg; $12–$60 for generic | Approximately $260 for one HFA inhaler (110 mcg) with about 120 doses |
| Generic Name | Montelukast | Fluticasone Propionate |
| Most Serious Side Effect | Mood changes like agitation/aggressiveness; depression; hallucinations; thoughts about suicide/harmful actions towards oneself | Signs of allergic reaction such as hives, difficulty breathing or swallowing, swelling in your face or throat; vision problems; white patches in the mouth or throat. |
| Severe Drug Interactions | Certain antifungal medicines (like ketoconazole), antibiotics (such as clarithromycin), and protease inhibitors used for HIV treatment may increase the concentration of montelukast. | Certain antifungal medicines, antibiotics, and protease inhibitors may increase the concentration of fluticasone, leading to more side effects. |
| Typical Dose | Adults and adolescents 15 years and older: 10 mg/day. Children 6-14 years: 5 mg/day. Children 2-5 years: 4 mg/day. | Children: 88 mcg twice daily. Adults: 88-220 mcg twice daily, up to a maximum of 880 mcg per day. |
What is Singulair?
Montelukast (the generic name for Singulair) is a type of leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Montelukast was first approved by the FDA in 1998. Singulair works by blocking substances in the body called leukotrienes that cause narrowing and swelling of airways in the lungs, thereby helping to improve breathing and reduce instances of using rescue inhalers. It is prescribed mainly for long-term prevention and treatment of asthma.
On the other hand, Fluticasone (the generic name for Flovent) belongs to a class of drugs known as corticosteroids which work directly within your lungs to decrease inflammation. This medication must be regularly used to prevent chest tightness, wheezing, coughing caused by asthma but it will not relieve an acute attack once started.
While both medications are effective at managing asthma symptoms, they work differently with varying side effects – Montelukast may lead rarely to serious mental/mood changes while Fluticasone might cause throat irritation or nosebleeds due its mode application via inhalation.
What conditions is Singulair approved to treat?
Singulair and Flovent are both approved for the treatment of asthma, but they have different applications:
- Singulair (montelukast) is a once-daily oral medication used to prevent asthma attacks in adults and children as young as 12 months old. It is also indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older.
- Flovent (fluticasone) is an inhaled corticosteroid that helps decrease inflammation in the lungs, making it easier to breathe. It's typically used twice daily by individuals aged four years or over to control their symptoms and improve lung function.
How does Singulair help with these illnesses?
Singulair helps to manage asthma and allergies by blocking the action of leukotrienes in the body. Leukotrienes are chemicals that cause inflammation, constriction of airways, and production of phlegm in response to an allergen or during an asthma attack. By preventing leukotriene synthesis or function, Singulair can help reduce these symptoms and improve respiratory function.
On the other hand, Flovent treats asthma by reducing inflammation directly within the lungs. It achieves this effect through its active ingredient fluticasone propionate—an inhaled corticosteroid—that works by inhibiting multiple types of cells (e.g., mast cells, eosinophils) and mediators (e.g., histamine, eicosanoids) involved in asthmatic responses.
Both medications aim to control long-term asthma symptoms but they do so via different pathways. Choosing between them depends on individual patient factors such as symptom severity, frequency of attacks, presence of coexisting conditions like allergies or exercise-induced bronchospasm among others.
What is Flovent?
Flovent is a brand name for fluticasone propionate, which is a corticosteroid that functions to reduce inflammation in the airways by mimicking the action of hormones that your body naturally produces. It works by suppressing or preventing many of the components of inflammatory responses in patients with asthma. Fluticasone was first approved by the FDA in 1990. As it acts locally within the respiratory system and does not have systemic effects, it does not cause sedation or weight gain (common side effects of other systemic steroids). Its targeted action on lung tissue means Flovent can effectively manage asthma symptoms without causing widespread side-effects throughout the body. The anti-inflammatory effects brought about by Flovent are beneficial for controlling asthma, especially for those who do not respond well to "typical" bronchodilators such as Singulair.
What conditions is Flovent approved to treat?
Flovent is a corticosteroid that's been approved for the management and prevention of asthma symptoms in patients aged four years and older. It works by reducing inflammation and swelling in the airways, making it easier to breathe. Some key conditions where Flovent is used are:
- Asthma
- Chronic obstructive pulmonary disease (COPD)
Please note, while Flovent can help prevent asthma attacks, it should not be used during an active attack as it will not provide immediate relief. A rescue inhaler would be more appropriate for such situations.
How does Flovent help with these illnesses?
Corticosteroids, such as those found in Flovent, work by reducing inflammation in the airways. This is critical for managing conditions like asthma and chronic obstructive pulmonary disease (COPD), where inflammation can lead to difficulty breathing and other symptoms. Flovent achieves this by acting directly on the lungs to suppress immune responses that trigger inflammation. It does not provide immediate relief from an acute attack but rather helps control symptoms over time.
While Singulair also has anti-inflammatory properties, it works slightly differently - it blocks leukotrienes, substances that cause tightening of the airway muscles and production of mucus. The emphasis here is on how Flovent's direct action in reducing inflammation makes it a preferred choice for many patients requiring long-term control medications for their respiratory conditions. In certain cases where a patient doesn't respond well enough to corticosteroids alone or needs additional help controlling symptoms, Flovent may be combined with other drugs such as leukotriene inhibitors like Singulair.
How effective are both Singulair and Flovent?
Both montelukast (Singulair) and fluticasone propionate (Flovent) are commonly used in managing asthma symptoms, though they utilize different mechanisms of action. Montelukast is a leukotriene receptor antagonist, which works by blocking the substances that trigger inflammation in the airways. On the other hand, fluticasone is an inhaled corticosteroid that reduces swelling and inflammation directly in the lungs.
Both drugs have been extensively studied for their effectiveness at alleviating symptoms of asthma. A 2003 study found similar efficacy between patients receiving either Singulair or Flovent as initial maintenance therapy for mild persistent asthma with no significant difference noted across various metrics such as peak expiratory flow rate or quality-of-life scores.
A 2010 review reported that montelukast was effective at controlling asthma from first dose onwards, had fewer side effects than many other drugs used to treat this condition, and was generally well-tolerated among different populations including children and elderly patients. Furthermore, it has also proven efficacy against exercise-induced bronchoconstriction.
On the contrary, a more recent meta-analysis conducted in 2019 concluded that while fluticasone appears to be more potent than placebo for treating asthmatic individuals; it's usually considered after leukotriene receptor antagonists like montelukast if control isn't achieved. There's substantial data confirming its efficacy both when administered alone or alongside another type of drug called long-acting beta agonists (LABAs). However evidence suggesting its role significantly amplifying effects of these LABAs remains somewhat limited. Despite this due to its unique pharmacology; Fluticasone may be a better option for those who haven’t responded well to Leukotriene Receptor Antagonists like Singulair or need additional control with minimum adverse events such as oral candidiasis or dysphonia.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Singulair typically prescribed?
Dosages of Singulair for adults and adolescents 15 years of age and older are typically 10 mg/day taken orally, which has been shown to be effective in treating asthma. Children aged 6-14 years may take a dose of 5 mg/day. For younger children aged 2-5 years, the dosage is reduced to a single daily intake of 4 mg. The dosage can be maintained or adjusted after some weeks based on response. However, it's important that the maximum dosage should not exceed these guidelines unless otherwise instructed by a healthcare provider.
At what dose is Flovent typically prescribed?
Flovent therapy is typically started at a dosage of 88 mcg twice daily for children and 88-220 mcg twice daily for adults. The dose can then be adjusted based on individual patient response, up to a maximum of 880 mcg per day divided into two doses, given morning and evening. Patients should note that the full therapeutic effect may take a week or more to occur. If symptoms do not improve after several weeks of this regimen, your doctor may consider increasing the dosage or switching medications.
What are the most common side effects for Singulair?
Common side effects of Singulair may include:
- Headache
- Stomach pain, heartburn
- Nausea, vomiting, diarrhea
- Cough, sore throat
- Sinusitis (inflammation of the sinus cavities in the head)
- Upper respiratory infection
- Fever
- Rash
On the other hand, Flovent is associated with different set of potential side effects which can include:
-Infections in your mouth or throat caused by a fungus (thrush)
-Hoarseness and voice changes
-Bruising and skin thinning
-Pneumonia or bronchitis
-Cough and sore throat
-Sinusitis
-Fever
Always consult your healthcare provider to ensure you have complete information about any medication's potential side effects.
Are there any potential serious side effects for Singulair?
Flovent and Singulair are both medications used to manage asthma symptoms, but they can have different side effects.
With Flovent (fluticasone), these may include:
- Signs of an allergic reaction such as hives, difficulty breathing or swallowing, swelling in your face or throat
- Vision problems including blurred vision, eye pain or redness, seeing halos around lights
- White patches in the mouth or throat
- Symptoms indicating high cortisol levels such as weight gain (especially in your face or upper body), slow wound healing, skin thinning/discoloration
- Wheezing, choking feeling after using this medication
For Singulair (montelukast), potential side effects include:
- Mood changes like agitation/aggressiveness; depression; hallucinations; thoughts about suicide/harmful actions towards oneself
- Flu-like symptoms – fever and swollen glands with rash on cheeks/nose that worsens under sun exposure
- Tingling sensation/numbness/pain associated with nerve damage
In case you experience any of these severe reactions while taking either drug consult your doctor immediately.
What are the most common side effects for Flovent?
While using Flovent, some individuals may experience certain side effects. These can include:
- Dry mouth or throat irritation
- Hoarseness and voice changes
- Cough and sore throat
- Headaches and dizziness
- Nausea or vomiting
- Stomach discomfort or pain
- Skin rash, itching, hives
- Changes in taste or smell sensations Note that serious but less common side effects such as rapid heart rate, chest pain, tremors or nervousness may require immediate medical attention. Also remember that long-term use of corticosteroids like Flovent has the potential to cause weight fluctuations, increased urination and muscle weakness. Always consult with your healthcare provider for any concerns regarding your medication.
Are there any potential serious side effects for Flovent?
While Flovent is generally well-tolerated, in some cases it can cause serious side effects. Symptoms that may be indicative of these include:
- Signs of allergic reaction: hives, difficulty breathing or swallowing, swelling in your face or lips, tongue or throat
- Skin rashes with blistering and peeling
- Worsening asthma symptoms or shortness of breath
- Vision problems such as blurred vision, eye pain or redness, seeing halos around lights
- White patches in the mouth and throat (signs of oral thrush)
- Unusual weight gain especially in your face and midsection
- Severe depression including feelings of extreme sadness, hopelessness, changes in behavior or thoughts about suicide
If you notice any of the above signs after starting treatment with Flovent, consult your doctor immediately.
Contraindications for Singulair and Flovent?
Both Singulair and Flovent, like most asthma medications, may cause side effects in some patients. If you notice your symptoms worsen or you experience chest pain, increased heart rate or palpitations after starting these medications, please seek immediate medical attention.
Neither Singulair nor Flovent should be used as a rescue inhaler during an acute asthma attack. They are meant for long-term control and management of asthma symptoms. Always have a short-acting bronchodilator such as albuterol available for emergency use.
It's important to inform your healthcare provider about all the medications you're taking before starting on either Singulair or Flovent; some drugs could interact with them potentially causing adverse reactions. For instance, certain antifungal medicines (like ketoconazole), antibiotics (such as clarithromycin), and protease inhibitors used for HIV treatment may increase the concentration of flovent in your body leading to more side effects.
Also note that sudden discontinuation of these drugs can lead to rebound worsening of your asthma symptoms; therefore always consult with your physician before making any changes to how you take these medications.
How much do Singulair and Flovent cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Singulair (10 mg) averages around $170, which works out to about $5.70/day.
- The price for one Flovent HFA inhaler (110 mcg), which provides about 120 doses, is approximately $260. If you are using two puffs twice daily as recommended for asthma treatment, this works out to roughly $4.35/day.
Thus, if you are taking the standard dose for each medication (i.e., one tablet per day for Singulair and two puffs twice a day from Flovent), then brand-name Flovent is less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which drug is right for your condition.
In terms of generic versions:
- Montelukast sodium (the generic version of Singulair) costs around $12–$60 for 30 tablets depending on the pharmacy's pricing; hence its daily cost ranges from about $0.40 - $2.
- There currently isn't an FDA-approved generic equivalent to Flovent HFA available in U.S market due to patent rights; thus patients seeking cheaper alternatives may consider other types of steroid inhalers that do have approved generics available after discussing options with their healthcare provider.
Popularity of Singulair and Flovent
Montelukast, also known by its brand name Singulair, was estimated to have been prescribed to about 8 million people in the US in 2020. Montelukast accounted for around 10% of prescriptions for leukotriene receptor antagonists (LTRAs), a class of drugs used primarily as controllers in managing chronic asthma and allergic rhinitis. The widespread use of montelukast has remained relatively steady over the past decade.
Fluticasone propionate, sold under the brand name Flovent among others, is an inhaled corticosteroid that helps control and prevent symptoms such as wheezing and shortness of breath caused by asthma. In contrast to montelukast's oral administration route, fluticasone is administered via inhalation directly into the lungs. Fluticasone was prescribed to approximately 6 million people in the US during 2020. It accounts for just above 15% of all inhaler-based steroid prescriptions within this same time period. Its usage trend has seen a marginal increase over last few years due largely to growing awareness about maintenance therapy for chronic obstructive pulmonary disease (COPD) and asthma.
Conclusion
Both Singulair (montelukast) and Flovent (fluticasone propionate) have long-standing records of usage in patients with asthma, backed by numerous clinical studies and meta-analyses indicating their efficacy. In some cases, these drugs may be used together to control severe or persistent asthma symptoms. However, due to their different mechanisms of action—Singulair being a leukotriene receptor antagonist that reduces inflammation in the lungs and Flovent being an inhaled corticosteroid that directly treats the airway inflammation—they are typically prescribed under varying circumstances.
Flovent is generally considered a first-line maintenance treatment for controlling persistent asthma whereas Singulair is often recommended as an add-on therapy to low-dose inhaled corticosteroids like Flovent or for those who cannot tolerate them.
Both medications are available in generic form which can result in significant cost savings especially for patients paying out-of-pocket. Both Singulair and Flovent require consistent use over time before full benefits are noticed.
In terms of side effects, both drugs are usually well-tolerated but come with their own set of potential side effects: Singulair may cause headache, stomach pain or heartburn while Flovent could lead to mouth thrush or hoarseness. For both medications, it's critical that patients monitor any unusual changes and seek medical attention if they experience severe reactions such as difficulty breathing.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Roeder, A., Schaller, M., Schäfer-Korting, M., & Korting, H. C. (2004, December 10). Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin Diseases. Skin Pharmacology and Physiology. S. Karger AG.http://doi.org/10.1159/000081680
- Storms, W. (2007, August 23). Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opinion on Pharmacotherapy. Informa UK Limited.http://doi.org/10.1517/14656566.8.13.2173
- Jayaram, L. (2005, January 1). Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma. European Respiratory Journal. European Respiratory Society (ERS).http://doi.org/10.1183/09031936.04.00008104
- Hamdan, S. J., Al-Attar, Z., & Hashim, I. (2019, July 20). Prevalence of Montelukast Use as an Add-On Therapy among Iraqi Asthmatics on Treatment Attending Al-Kindy Teaching Hospital and Al-Zahraa Center of Asthma and Allergy. Open Access Macedonian Journal of Medical Sciences. Scientific Foundation SPIROSKI.http://doi.org/10.3889/oamjms.2019.645
- Henriksen, D. P., Davidsen, J. R., Laursen, C. B., Christiansen, A., Damkier, P., Hallas, J., & Pottegård, A. (2017, June 22). Montelukast use—a 19-year nationwide drug utilisation study. European Journal of Clinical Pharmacology. Springer Science and Business Media LLC.http://doi.org/10.1007/s00228-017-2286-3
- Zeiger, R. S., Bird, S. R., Kaplan, M. S., Schatz, M., Pearlman, D. S., Orav, E. J., … Edelman, J. M. (2005, June). Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. The American Journal of Medicine. Elsevier BV.http://doi.org/10.1016/j.amjmed.2005.03.003
- Busse, W., Raphael, G. D., Galant, S., Kalberg, C., Goode-Sellers, S., Srebro, S., … Rickard, K. (2001, March). Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. Elsevier BV.http://doi.org/10.1067/mai.2001.114657